Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    Synchrony Financial (SYF) Insider Trading Activity

    Financial Services • Credit Services • 20,000 employees

    Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products, such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts, and sweep and affinity deposits, as well as accepts deposits through third-party securities brokerage firms. In addition, it provides debt cancellation products to its credit card customers through online, mobile, and direct mail; and healthcare payments and financing solutions under the CareCredit and Walgreens brands; payments and financing solutions in the apparel, specialty retail, outdoor, music, and luxury industries, such as American Eagle, Dick's Sporting Goods, Guitar Center, Kawasaki, Pandora, Polaris, Suzuki, and Sweetwater. The company offers its credit products through programs established with a group of national and regional retailers, local merchants, manufacturers, buying groups, industry associations, and healthcare service providers; and deposit products through various channels, such as digital and print. It serves digital, health and wellness, retail, home, auto, telecommunications, jewelry, pets, and other industries. The company was founded in 1932 and is headquartered in Stamford, Connecticut.

    Total Value

    $1,743,180.41

    Total Shares

    41,533

    Average Trade Value

    $14,648.57

    Most Active Insider

    Doubles Brian D

    Total Activity: $42,667,667

    Largest Single Transaction

    $14,952,098

    by Doubles Brian D on Jan 21, 2025

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    See Remarks
    Officer
    Mar 3, 2025 363 $22,190 57,750 (-0.6%) Sale
    See Remarks
    Officer
    Mar 3, 2025 38,005 $2,252,936 57,650 (-65.9%) Sale
    See Remarks
    Officer
    Mar 3, 2025 10,010 $600,700 18,808 (-53.2%) Sale
    See Remarks
    Officer
    Mar 3, 2025 11,075 $664,611 22,339 (-49.6%) Sale
    See Remarks
    Officer
    Mar 3, 2025 8,964 $262,914 107,856 (+8.3%) Exercise/Conversion
    See Remarks
    Officer
    Mar 3, 2025 10,490 $614,504 95,655 (-11.0%) Sale
    See Remarks
    Officer
    Mar 3, 2025 58,026 $3,482,140 56,462 (-102.8%) Sale
    See Remarks
    Officer
    Mar 3, 2025 6,632 $201,679 114,488 (+5.8%) Exercise/Conversion
    See Remarks
    Officer
    Mar 3, 2025 10,528 $604,518 106,145 (-9.9%) Sale
    See Remarks
    Officer
    Mar 3, 2025 200 $12,218 41,562 (-0.5%) Sale
    See Remarks
    Officer
    Mar 3, 2025 14,453 $495,738 102,125 (+14.2%) Exercise/Conversion
    See Remarks
    Officer
    Mar 3, 2025 62,702 $3,762,747 68,249 (-91.9%) Sale
    See Remarks
    Officer
    Mar 3, 2025 34,043 $2,042,920 107,816 (-31.6%) Sale
    See Remarks
    Officer
    Mar 3, 2025 14,548 $487,794 116,673 (+12.5%) Exercise/Conversion
    See Remarks
    Officer
    Mar 3, 2025 12,367 $724,335 123,619 (-10.0%) Sale
    See Remarks
    Officer
    Mar 3, 2025 13,177 $756,755 135,986 (-9.7%) Sale
    See Remarks
    Officer
    Mar 3, 2025 15,888 $960,906 41,762 (-38.0%) Sale
    See Remarks
    Officer
    Mar 3, 2025 19,404 $1,173,748 58,113 (-33.4%) Sale
    See Remarks
    Officer
    Mar 3, 2025 16,613 $569,826 131,018 (+12.7%) Exercise/Conversion
    See Remarks
    Officer
    Mar 3, 2025 18,145 $608,402 149,163 (+12.2%) Exercise/Conversion
    See Remarks
    Officer
    Mar 3, 2025 46,102 $2,733,388 77,517 (-59.5%) Sale
    See Remarks
    Officer
    Mar 1, 2025 10,865 $659,288 87,672 (-12.4%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 16,640 $1,009,715 98,537 (+16.9%) Grant
    See Remarks
    Officer
    Mar 1, 2025 29,664 $1,800,012 148,678 (+20.0%) Grant
    See Remarks
    Officer
    Mar 1, 2025 12,844 $779,374 167,153 (-7.7%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 24,102 $1,462,509 179,997 (+13.4%) Grant
    See Remarks
    Officer
    Mar 1, 2025 17,727 $1,075,674 130,951 (-13.5%) Payment of Exercise Price
    See Remarks
    Director, Officer
    Mar 1, 2025 66,780 $4,052,210 712,611 (-9.4%) Payment of Exercise Price
    See Remarks
    Director, Officer
    Mar 1, 2025 101,970 $6,187,540 779,391 (+13.1%) Grant
    See Remarks
    Officer
    Mar 1, 2025 20,302 $1,231,925 113,824 (+17.8%) Grant
    See Remarks
    Officer
    Mar 1, 2025 3,152 $191,263 19,427 (+16.2%) Grant
    See Remarks
    Officer
    Mar 1, 2025 14,932 $906,074 98,892 (-15.1%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 7,416 $450,003 31,588 (+23.5%) Grant
    See Remarks
    Officer
    Mar 1, 2025 2,770 $168,084 28,818 (-9.6%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 12,052 $731,315 141,859 (-8.5%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 2,688 $163,108 33,414 (-8.0%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 7,416 $450,003 36,102 (+20.5%) Grant
    See Remarks
    Officer
    Mar 1, 2025 20,302 $1,231,925 153,911 (+13.2%) Grant
    See Remarks
    Officer
    Mar 1, 2025 15,518 $941,632 114,405 (-13.6%) Payment of Exercise Price
    See Remarks
    Officer
    Mar 1, 2025 24,102 $1,462,509 129,923 (+18.6%) Grant
    See Remarks
    Director, Officer
    Feb 28, 2025 2,157 $130,671 824,011 (-0.3%) Sale
    See Remarks
    Director, Officer
    Feb 28, 2025 19,365 $1,162,868 777,421 (-2.5%) Sale
    See Remarks
    Director, Officer
    Feb 28, 2025 28,019 $821,797 826,168 (+3.4%) Exercise/Conversion
    See Remarks
    Director, Officer
    Feb 28, 2025 91,154 $5,473,798 677,421 (-13.5%) Sale
    See Remarks
    Director, Officer
    Feb 28, 2025 1,363 $82,625 796,786 (-0.2%) Sale
    See Remarks
    Director, Officer
    Feb 28, 2025 25,862 $1,552,754 798,149 (-3.2%) Sale
    See Remarks
    Director, Officer
    Feb 28, 2025 8,846 $535,979 768,575 (-1.2%) Sale
    See Remarks
    Director, Officer
    Feb 28, 2025 20,728 $630,338 798,149 (+2.6%) Exercise/Conversion
    Director
    Feb 18, 2025 107 $6,986 46,058 (+0.2%) Grant
    Director
    Feb 18, 2025 13 $849 47,498 (+0.0%) Grant
    See Remarks
    Officer
    Feb 18, 2025 222 $14,494 93,522 (+0.2%) Grant
    See Remarks
    Officer
    Feb 18, 2025 222 $14,494 133,609 (+0.2%) Grant
    Director
    Feb 18, 2025 13 $849 27,183 (+0.0%) Grant
    Director
    Feb 18, 2025 122 $7,965 34,981 (+0.3%) Grant
    See Remarks
    Officer
    Feb 18, 2025 69 $4,505 24,172 (+0.3%) Grant
    See Remarks
    Officer
    Feb 18, 2025 191 $12,470 81,897 (+0.2%) Grant
    See Remarks
    Director, Officer
    Feb 18, 2025 1,167 $76,193 777,421 (+0.2%) Grant
    Director
    Feb 18, 2025 156 $10,185 86,730 (+0.2%) Grant
    Director
    Feb 18, 2025 123 $8,031 46,654 (+0.3%) Grant
    Director
    Feb 18, 2025 3 $196 638 (+0.5%) Grant
    See Remarks
    Officer
    Feb 18, 2025 256 $16,714 105,821 (+0.2%) Grant
    Director
    Feb 18, 2025 13 $849 25,216 (+0.1%) Grant
    Director
    Feb 18, 2025 13 $849 12,872 (+0.1%) Grant
    See Remarks
    Officer
    Feb 18, 2025 62 $4,048 16,275 (+0.4%) Grant
    See Remarks
    Officer
    Feb 18, 2025 228 $14,886 155,895 (+0.1%) Grant
    Director
    Feb 18, 2025 13 $849 29,429 (+0.0%) Grant
    See Remarks
    Officer
    Feb 18, 2025 293 $19,130 119,014 (+0.2%) Grant
    See Remarks
    Officer
    Feb 18, 2025 80 $5,223 28,686 (+0.3%) Grant
    See Remarks
    Director, Officer
    Jan 21, 2025 215,231 $14,952,098 876,051 (+24.6%) Grant
    See Remarks
    Officer
    Jan 21, 2025 25,635 $1,780,863 133,387 (-19.2%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 78,743 $5,470,276 155,287 (+50.7%) Grant
    See Remarks
    Officer
    Jan 21, 2025 30,581 $2,124,462 93,300 (-32.8%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 29,557 $2,053,325 105,565 (-28.0%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 68,246 $4,741,050 135,122 (+50.5%) Grant
    See Remarks
    Officer
    Jan 21, 2025 36,566 $2,540,240 118,721 (-30.8%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 8,925 $620,020 26,821 (+33.3%) Grant
    See Remarks
    Officer
    Jan 21, 2025 59,057 $4,102,690 123,881 (+47.7%) Grant
    See Remarks
    Officer
    Jan 21, 2025 3,328 $231,196 28,606 (-11.6%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 11,025 $765,907 31,934 (+34.5%) Grant
    See Remarks
    Director, Officer
    Jan 21, 2025 99,797 $6,932,898 776,254 (-12.9%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 59,057 $4,102,690 159,022 (+37.1%) Grant
    See Remarks
    Officer
    Jan 21, 2025 52,497 $3,646,967 102,347 (+51.3%) Grant
    See Remarks
    Officer
    Jan 21, 2025 20,641 $1,433,930 81,706 (-25.3%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 24,417 $1,696,249 155,667 (-15.7%) Payment of Exercise Price
    See Remarks
    Officer
    Jan 21, 2025 52,497 $3,646,967 180,084 (+29.2%) Grant
    See Remarks
    Officer
    Jan 21, 2025 2,718 $188,819 24,103 (-11.3%) Payment of Exercise Price
    Director
    Dec 31, 2024 1,116 $72,551 86,574 (+1.3%) Grant
    Director
    Dec 31, 2024 635 $41,281 25,203 (+2.5%) Grant
    Director
    Dec 31, 2024 635 $41,281 27,170 (+2.3%) Grant
    Director
    Dec 31, 2024 635 $41,281 635 (+100.0%) Grant
    Director
    Dec 31, 2024 635 $41,281 46,531 (+1.4%) Grant
    Director
    Dec 31, 2024 635 $41,281 29,416 (+2.2%) Grant
    Director
    Dec 31, 2024 635 $41,281 45,951 (+1.4%) Grant
    Director
    Dec 31, 2024 635 $41,281 12,859 (+4.9%) Grant
    Director
    Dec 31, 2024 635 $41,281 47,485 (+1.3%) Grant
    Director
    Dec 31, 2024 635 $41,281 34,859 (+1.8%) Grant
    See Remarks
    Officer
    Nov 15, 2024 80 $5,198 20,909 (+0.4%) Grant
    Director
    Nov 15, 2024 15 $975 28,781 (+0.1%) Grant
    Director
    Nov 15, 2024 105 $6,823 45,316 (+0.2%) Grant
    Director
    Nov 15, 2024 15 $975 46,850 (+0.0%) Grant
    See Remarks
    Officer
    Nov 15, 2024 62 $4,029 16,213 (+0.4%) Grant
    See Remarks
    Officer
    Nov 15, 2024 16,163 $1,050,433 145,587 (-11.1%) Sale
    See Remarks
    Officer
    Nov 15, 2024 222 $14,426 64,824 (+0.3%) Grant
    See Remarks
    Officer
    Nov 15, 2024 229 $14,880 145,587 (+0.2%) Grant
    See Remarks
    Director, Officer
    Nov 15, 2024 1,168 $75,897 660,820 (+0.2%) Grant
    See Remarks
    Officer
    Nov 15, 2024 256 $16,635 66,876 (+0.4%) Grant
    See Remarks
    Officer
    Nov 15, 2024 191 $12,411 49,850 (+0.4%) Grant
    See Remarks
    Officer
    Nov 15, 2024 69 $4,484 17,896 (+0.4%) Grant
    See Remarks
    Officer
    Nov 15, 2024 222 $14,426 99,965 (+0.2%) Grant
    Director
    Nov 15, 2024 121 $7,863 45,896 (+0.3%) Grant
    Director
    Nov 15, 2024 15 $975 24,568 (+0.1%) Grant
    Director
    Nov 15, 2024 15 $975 26,535 (+0.1%) Grant
    Director
    Nov 15, 2024 121 $7,863 58,330 (+0.2%) Grant
    Director
    Nov 15, 2024 153 $9,942 85,458 (+0.2%) Grant
    See Remarks
    Officer
    Nov 15, 2024 18,000 $1,169,820 127,587 (-14.1%) Sale
    See Remarks
    Officer
    Nov 15, 2024 293 $19,039 76,544 (+0.4%) Grant
    See Remarks
    Officer
    Nov 15, 2024 16,163 $491,517 161,750 (+10.0%) Exercise/Conversion
    Director
    Nov 15, 2024 15 $975 12,224 (+0.1%) Grant
    See Remarks
    Officer
    Nov 1, 2024 21,934 $1,209,221 99,743 (-22.0%) Sale